- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06494306
Characterization of Olfactory Perception in Post-Traumatic Stress Disorder (TRAUMODO)
The core symptoms of post-traumatic stress disorder (PTSD) include flash backs, intrusive pictures and thoughts related to the traumatic event, hyperalertness, avoidance of traumatic relevant environmental triggers and emotional dysregulation. Some studies suggest that PTSD is also associated with impaired olfactory perception, which seems quite intuitive regarding the close anatomical-functional connections between olfactory and emotional circuits. Furthermore, some studies reported that olfactory stimuli can trigger flashbacks in subjects with PTSD. However, up to know available data is scarce and heterogeneous concerning that topic. The goal of the study is to determine the olfactory phenotype of subjects with PTSD. More precisely, this project aims at filling the above mentioned gap by systematically assessing the olfactory perception of subjects with PTSD along five dimensions: olfactory identity, hedonic value, familiarity, desirability and edibility. As a secondary goal, the relative weight of olfaction compared to the other senses in the relived memories of subjects with PTSD will be assessed.
The investigators here hypothesize a global impairment in olfactory processing (intensity, hedonicity, familiarity and edibility judgments) in PTSD subjects, compared with healthy subjects.
Study Overview
Status
Conditions
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: VIGNAUD Philippe, MD, PhD
- Phone Number: +33472116396
- Email: philippe.vignaud@chu-lyon.fr
Study Contact Backup
- Name: GALIA Perrine, CRA
- Phone Number: +33472111311
- Email: perrine.galia@chu-lyon.fr
Study Locations
-
-
-
Lyon, France, 69003
- Auvergne-Rhône-Alpes Regional Center for Psychotrauma
-
Contact:
- VIGNAUD Philippe, MD, PhD
- Phone Number: +33472116396
- Email: philippe.vignaud@chu-lyon.fr
-
Principal Investigator:
- VIGNAUD Philippe, MD, PhD
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age between 18 to 50
- Subjects with PTSD
Exclusion Criteria:
- Patients with a neurological history such as stroke, head trauma (e.g. exposure to explosions, sports injury…), neurodegenerative disease…
- Any psychiatric condition except PTSD and major depressive disorder
- Current or recent use of psychotropic drugs that may affect olfactory function.
- Any current or remitted addictive disorder.
- Pregnancy and breast-feeding women
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patients with PTSD
They are outpatients receiving psychological and medical treatment in the clinical department connected to the inclusion site
|
Investigators will collect the ETOC score in patient of both arms
To smell 20 odorant solutions and for each odor and evaluate it along five dimensions: familiarity, hedonicity, edibility, desire to smell again, perceived intensity).
Each dimension is assessed with a Likert scale (from 1 (not at all) to 9 (extremely))
Patients with PTSD will have the following questionnaires : PTSD Checklist for Diagnostic and Statistical Manual (DSM)-V (PCL-5), Peri-trauma Dissociation Experience Questionnaire (PDEQ), Patient Health Questionnaire-9 (PHQ9), Snaith-Hamilton Pleasure Scale (SHAPS), Childhood Trauma Questionnaire (CTQ) and Apathy Evaluation Scale (AES)
Patients with PTSD will have Odor / trauma association questionnaire
|
|
Control group
Data from subjects without PTSD included in a previous study
|
Investigators will collect the ETOC score in patient of both arms
To smell 20 odorant solutions and for each odor and evaluate it along five dimensions: familiarity, hedonicity, edibility, desire to smell again, perceived intensity).
Each dimension is assessed with a Likert scale (from 1 (not at all) to 9 (extremely))
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Standardized Hedonicity Test score
Time Frame: at inclusion
|
Results obtained in patients will be compared to those obtained in control group
|
at inclusion
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Effects of potential moderators on odor judgement
Time Frame: at inclusion
|
Analysis of covariance (ANCOVA) to determine the effect of different moderators (age, gender, type of trauma, time elapsed since trauma, type of treatment received, symptom intensity) on olfactory perception
|
at inclusion
|
|
Evaluation of sensory impressions of memories evoked by certain odors.
Time Frame: at inclusion
|
Sensory impressions: Nature and frequency of sensory descriptions associated with odor-evoked memories
|
at inclusion
|
|
Evaluation of emotional valence of memories evoked by certain odors.
Time Frame: at inclusion
|
Language analysis: Use of Natural Language Processing (NLP) techniques to assess the emotional valence of odor-evoked memories and recurrent themes in oral responses concerning evoked memories.
Analysis of the association of trauma-related odors with the 5 senses
|
at inclusion
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: VIGNAUD Philippe, MD, PhD, Auvergne-Rhône-Alpes Regional Center for Psychotrauma
Study record dates
Study Major Dates
Study Start (Estimated)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 69HCL24_0189
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Post Traumatic Stress Disorder
-
Acacia ClinicsElectroCore INC; Vagus Nerve SocietyRecruitingPTSD | Post Traumatic Stress Disorder | Post Traumatic Stress Disorders | Post-traumatic Stress Disorder (PTSD) | Post Traumatic Stress Disorder PTSD | PTSD - Post Traumatic Stress Disorder | Post-Traumatic Stress Disorder, PTSDUnited States
-
University of LuxembourgQuresta, Inc.; National Psychological Association of Ukraine; Veteran Mental...RecruitingPost Traumatic Stress Disorder | Post Traumatic Stress Disorder PTSD | Post-Traumatic Stress Disorder, PTSDUkraine
-
Istanbul UniversityRecruitingComplex Post-Traumatic Stress Disorder (CPTSD) | Post-traumatic Stress Disorder (PTSD)Turkey
-
Istanbul UniversityRecruitingComplex Post-Traumatic Stress Disorder (CPTSD) | Post-traumatic Stress Disorder (PTSD)Turkey
-
University of California, Los AngelesDefense Advanced Research Projects Agency; Defense Group, Inc.CompletedPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder, ChronicUnited States
-
University of California, Los AngelesWithdrawnPost-traumatic Stress Disorder | Post-Traumatic Stress Disorder in ChildrenUnited States
-
IWK Health CentreRecruitingPost-Traumatic Stress Disorder in Adolescence | Post-Traumatic Stress Disorder, PTSD | Post-Traumatic Stress Disorder in YouthCanada
-
Weill Medical College of Cornell UniversityCompletedPost-traumatic Stress Disorder | Complex Post-Traumatic Stress DisorderUnited States
-
University of UtahEunice Kennedy Shriver National Institute of Child Health and Human Development...CompletedPost-Traumatic Stress Disorder in Children | Post-Traumatic Stress Disorder in AdolescenceUnited States
-
University of ZurichCompletedPost Traumatic Stress Disorder (PTSD) | Complex Post-Traumatic Stress Disorder (CPTSD)Switzerland
Clinical Trials on European Test of Olfactory Capabilities (ETOC)
-
University of GiessenUniversity of Kiel; Masaryk UniversityRecruitingDysgeusia | Olfactory Disorder | Oral ComplicationGermany
-
Taichung Veterans General HospitalCompleted
-
H. Lee Moffitt Cancer Center and Research InstitutePfizerCompletedRenal Cell Carcinoma Stage IVUnited States
-
RWTH Aachen UniversityRecruitingFibrosis | Asthma | Pulmonary Hypertension | COPD | Dyspnea | Dyspnea; AsthmaticGermany
-
Centre Antoine LacassagneUniversity of Lyon; University of Firenze and Siena, Napoli, ItalyCompleted
-
Chang Gung Memorial HospitalRecruitingPostoperative Complications | Enhanced Recovery After Surgery | Pituitary TumorTaiwan
-
Anchora MedicalCompleted
-
H. Lee Moffitt Cancer Center and Research InstituteKite, A Gilead CompanyCompletedDiffuse Large B Cell Lymphoma | Transformed LymphomaUnited States